GNLX · GENELUX Corp
$2.58
-0.09 (-3.20%)
At close · Aug 31
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company has experienced recurring losses from operations since inception and incurred a net loss of $18.4 million and cash used in operations of $12.5 million during the six months ended June 30, 2026. These factors raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$120.35M
Shares
45.25M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-03-02 | TD Cowen 46th Annual Health Care Conference | Conference |
| 2026-02-25 | Oppenheimer 36th Annual Healthcare Life Sciences Conference | Conference |
| 2026-01-19 | Virtual Fireside Chat Hosted by Titan Partners | Webcast |
| 2025-12-03 | Piper Sandler 37th Annual Healthcare Conference | Conference |
| 2025-08-27 | 2025 Genelux Annual Stockholder Meeting | Shareholder meeting |
| 2025-05-08 | The Citizens Life Sciences Conference Fireside Chat | Conference |
| 2024-12-16 | HC Wainwright at Home with Genelux Corporation | Webcast |
| 2024-09-11 | H.C. Wainwright Global Investment Conference Fireside Chat | Conference |
Source: https://investors.genelux.com/
Key facts
CIK
1231457
CUSIP
36870H103
13F (30d)
48 filings
48 filers
Visit website
Investor relations